期刊文献+

菊花黄酮及其水解产物效应成分在家兔体内动力学研究 被引量:5

Phannacokinetics of active component of Chrysanthemum morifolium extracts and its acid hydrolysate in rabbits
下载PDF
导出
摘要 目的 比较家兔口服菊花提取物(CME)及其酸水解产物后,其效应成分(木犀草素和芹菜素)的动力学参数,阐明菊花黄 酮给药形式对其生物利用度的影响。方法 健康家兔单剂量(200mg·k-1)灌胃CME及其酸水解产物,以RP-HPLC测定给药 后不同时间点木犀草素和芹菜素血浆药物浓度。使用3P87软件拟合药动学参数,Microsoft Excel软件进行数据统计分析。结 果 家兔灌胃CME或其酸水解产物,血浆中木犀草素浓度较高,其药动学过程符合一室模型,血浆中芹菜素浓度在定量限以 下。两种形式给予家兔灌胃后,所得木犀草素药动学参数表明,与CME给药比较,以水解CME给家兔灌胃,木犀草素在其体 内的血药浓度达峰时间tmax滞后,最高血药浓度ρmax降低,而平均滞留时间MRT延长。结论 经Microsoft Excel软件统计分析, 以原型CME或水解CME给健康家兔灌胃,即CME中黄酮类化合物以苷或苷元的形式给药,在家兔体内的生物利用度无显著 性差异(P>0.05)。 OBJECTIVE To characterize and compare the metabolic pharmacokinetics of the active components ( luteolin and apigenin) in rabbit after an oral administration of acid hydrolysate of Chrysanthemum morifolittm extracts (CME) or intact CME, and clarify whether the bioavailability of flavoloids from Chrysanthemum morifolium Ramat. would be modified due to the preparation of flavonoids forms. METHODS The concentrations of luteolin and apigenin in plasma were determined by HPLC method after a single oral dose of 200 mg·kg^-1 of intact CME and hydrolysate of CME was administered to rabbits. The pharmacokinetic parameters were calculated by software 31987 and statistical analysis was performed by software Microsoft Excel. RESULTS The plasma concentration of luteolin was determined accurately and the pharmacokinetic profile was discribed by an one-compartment model. However, the present study showed that the concentration of apigenin was too low to be measured accurately. There were some differences in pharmacokinetic parameters for active component (luteolin) between the hydrolysate of CME and intact CME apparently. Furthermore, the oral hydrolysate of CME resulted in a delayed tmax, lower ρmax and longer MRT (mean residence time) for luteolin than those after an oral dose of intact CME. CONCLUSION By statistical analysis, the bioavailability of luteolin reveals no significant difference ( P 〉 0.05) after an oral administration of acid hydrolysate of CME or intact CME to rabbit.
出处 《中国药学杂志》 EI CAS CSCD 北大核心 2005年第24期1884-1887,共4页 Chinese Pharmaceutical Journal
基金 浙江省中医药局(G20010358)浙江省科技厅(G20020578)浙江省自然基金重点资助项目(Y204379)
关键词 菊花提取物 木犀草素 芹菜素 药动学 Chrysanthemum morifolium Extracts luteolin apigenin pharmacokinetics
  • 相关文献

参考文献6

二级参考文献28

  • 1汪民海.安徽产三种菊花总黄酮量的比色测定[J].基层中药杂志,1997,11(2):37-38. 被引量:24
  • 2江苏新医学院.中药大辞典(下册)[M].上海:上海人民出版社,1997.1496.
  • 3.中国药典2000年版[S]:一部[M].,2000.253~254.
  • 4江苏新医学学院,中药大辞典.下,1997年
  • 5Shekher A, Singh M. Role of Eicosanoid inhibition of ischemia reperfusion injury: intact and isolated rat heart studies[J]. Methods Find Exp Clin Pharmacol, 1997, 19(4): 223-239.
  • 6Post JM, Gelband CH, Hume JR. [Ca2+]i inhibition of K+ channels in canine pulmonary artery. Novel mechanism for hypoxia-induced membrane depolarization[J]. Circ Res, 1995, 77(1): 131-139.
  • 7Zhuang J, Zhou Z. Protective effects of intermittent hypoxia adaptation on myocardium and its mechanism[J]. Biol Signals Recept, 1999, 8(4-5): 316-322.
  • 8Okabe E, Odajima C, Taga R, et al. The effect of oxygen free radicals on calcium permeability and calcium loading at steady state in cardiac sarcoplasmic reticulum[J]. Mol Pharmacol, 1988, 34(3): 388-394.
  • 9杨学运 孙孔富 等.中药杭白菊酚性部分的药理作用探讨[J].浙江医科大学学报,1989,18(6):282-282.
  • 10戴广钧 见:王浴生 邓文龙 薛春生 等主编.菊花[A].见:王浴生,邓文龙,薛春生,等主编.中药药理与应用[M]. 第2版[C].北京: 人民卫生出版社,1998.968-971.

共引文献168

同被引文献36

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部